ANVLX | OAZIX | ANVLX / OAZIX | |
Total Expense Ratio | 1.44 | 0.75 | 192% |
Annual Report Gross Expense Ratio | 1.44 | 0.75 | 192% |
Fund Existence | 6 years | 5 years | - |
Gain YTD | 27.840 | 21.933 | 127% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 588M | 14.4B | 4% |
Annual Yield % from dividends | 2.12 | 2.34 | 91% |
Returns for 1 year | 6.34 | 16.07 | 39% |
Returns for 3 years | 35.58 | 44.02 | 81% |
Returns for 5 years | 43.95 | N/A | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XPH | 42.62 | 0.35 | +0.83% |
SPDR® S&P Pharmaceuticals ETF | |||
HARD | 29.11 | 0.08 | +0.28% |
Simplify Commodities Strategy No K-1 ETF | |||
CPSD | 24.95 | 0.06 | +0.23% |
Calamos S&P 500 Str Alt Prt ETF-Dec | |||
TOTR | 40.22 | -0.01 | -0.02% |
T. Rowe Price Total Return ETF | |||
GDXJ | 66.76 | -0.73 | -1.08% |
VanEck Junior Gold Miners ETF |